the market loves it. Preliminary “data” from 14 patients for a trial that was committed to in 2014. Should expand market size by 30 -40 patients. Trial performed after ema rejection. Love this company.
Ann: Preliminary results from SCENESSE adolescent EPP study, page-4
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
$9.70 |
Change
-0.060(0.61%) |
Mkt cap ! $487.2M | |||
| Open | High | Low | Value | Volume |
| $9.58 | $9.90 | $9.44 | $1.179M | 121.6K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 8 | 299 | $9.70 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $9.73 | 784 | 17 |
View Market Depth
| Last trade - 15.51pm 18/06/2025 (20 minute delay) ? |
| CUV (ASX) Chart |